Cargando…
A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease
BACKGROUND: Increased expression of toll-like receptor 4 (TLR4) and its endogenous ligands, is characteristic of rheumatoid arthritis (RA) synovitis. In this study, we evaluated how these TLR4 ligands may drive pathogenic processes and whether the fine profiling of anti-citrullinated protein antibod...
Autores principales: | Hatterer, Eric, Shang, Limin, Simonet, Pierre, Herren, Suzanne, Daubeuf, Bruno, Teixeira, Stéphanie, Reilly, James, Elson, Greg, Nelson, Robert, Gabay, Cem, Sokolove, Jeremy, McInnes, Iain B., Kosco-Vilbois, Marie, Ferlin, Walter, Monnet, Emmanuel, De Min, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053084/ https://www.ncbi.nlm.nih.gov/pubmed/27716430 http://dx.doi.org/10.1186/s13075-016-1128-5 |
Ejemplares similares
-
Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferation
por: Hatterer, Eric, et al.
Publicado: (2019) -
Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors: Fc-mediated avidity enhances the potency of an anti-TLR4 antibody
por: Loyau, Jérémy, et al.
Publicado: (2014) -
The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases
por: Gabay, Cem, et al.
Publicado: (2009) -
Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis
por: Gabay, Cem, et al.
Publicado: (2016) -
Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis
por: Lima, Cristiano Xavier, et al.
Publicado: (2015)